Alto Neuroscience Initiated at Buy by Jones Trading

Dow JonesDec 16 08:21 ET · Ratings

This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BenzingaDec 16 08:17 ET

JonesTrading Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $18

Moomoo NewsDec 16 07:31 ET · Ratings

Express News | Alto Neuroscience Highlights Data From Precision Psychiatry Platform At ACNP Annual Meeting; Interim Analysis For ALTO-300 Phase 2b Trial In MDD Expected Q1 2025, With Topline Results In H1 2025

BenzingaDec 11 08:14 ET

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

BusinesswireDec 11 08:03 ET

Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

TipRanksNov 14 02:36 ET